All lobbying filings

S-3 GROUP

S-3 GROUP filed a Q1 report for GOODRX on April 17, 2026, reporting $60,000 in lobbying income.

Lobbying for GOODRX · Healthcare company

All filings by S-3 GROUP · Everything GOODRX has reported

Filing · LD-2 quarterly report Q1 report

Reporting period

1st Quarter 2026

Jan 1 - Mar 31 · Posted Apr 17, 2026

Income

$60,000

What the client paid this registrant for the period.

Client based in

California

Official filing document

Lobbyists on this filing 4

CHRISTOPHER BUKI

Previously held: Staff Assistant/Legislative Correspondent, Representative John Culberson; Legislative Assistant/Senior Legislative Assistant, Representative Bill Shuster; Legislative Director/Deputy Chief of Staff, Representative David McKinley
KRISTI REMINGTON

Previously held: Deputy Assistant Attorney General, US Department of Justice; Senior Counsel, House Government Reform Committee
MICHAELEEN EARLE CROWELL

Previously held: Leg Director, Rep. Denise Majette; Leg Director, Rep. John Lewis; Chief of Staff, US Sen. Bernie Sanders
MARTIN REISER

Previously held: Policy Director, Republican Whip Steve Scalise, professional staff House Ways and Means Committee, Chief of Staff, Rep. Dan Miller, Budget Associate, House Budget Committee

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 2

Pharmacy

Issues regarding lower prescription drug prices for patients

Health Issues

Issues regarding lower prescription drug prices for patients

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.